Preterm Delivery Risk Prediction by Measurement of Prenatal Serum Screening Markers

Status unconfirmed

Conditions studied: Preterm Delivery

In brief

This protocol seeks to longitudinally collect blood samples from a cohort of pregnant women. The biological specimens will be used to determine the predictive power of biochemical markers routinely used in Down syndrome screening in the assessment of patient's risk of preterm delivery.

Key facts

Study ID

NCT01009723

Run by

Esoterix Genetic Laboratories, LLC

People needed

2000

Starts

2010-03-01

Expected to finish

2012-07-01

Last updated by the study team

2012-06-08

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• The participant understands the nature of the study and its requirements. To this end, we will require that the participants have command of the English language.
• The participant consents to and signs the approved consent form.
• The participant is 18 years of age or older.
• The participant has a singleton pregnancy.
• The participant is planning on continuing the pregnancy.
• The participant has intent to clinically test for Down syndrome risk.
• The participant consents to the study at the first trimester of her pregnancy.
• The participant understands the nature of the study and its requirements. To this end, we will require that the participants have command of either the English or Spanish language.

You may not qualify if…

• N/A

Where it is running

• Integrated Genetics — Westborough, Massachusetts, United States
• Integrated Genetics — Santa Fe, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.